<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862220</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.991</article-id><article-id pub-id-type="other">EPV0241</article-id><article-id pub-id-type="pii">S092493382400991X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Comorbidity of mental disorders in synthetic cannabinoids abuse: clinical dynamics, behavior, adaptation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Selivanov</surname><given-names>G.</given-names></name><xref rid="aff2262" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2263" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff2264" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff2265" ref-type="aff">
<sup>4</sup>
</xref><xref rid="cor0847" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bokhan</surname><given-names>N.</given-names></name><xref rid="aff2262" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2266" ref-type="aff">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="aff2262"><sup>1</sup><institution>Mental Health Research Institute</institution>, <city>Tomsk</city></aff><aff id="aff2263">
<sup>2</sup>
<institution>Saint Petersburg University of State Fire Service of Emercom of Russia</institution>
</aff><aff id="aff2264">
<sup>3</sup>
<institution>Psychiatric Hospital of St. Nicholas the Wonderworker</institution>
</aff><aff id="aff2265"><sup>4</sup><institution>Rehabilitation Treatment Center &#x0201c;Child Psychiatry</institution>, <city>St. Petersburg</city></aff><aff id="aff2266"><sup>5</sup><institution>Siberian State Medical University</institution>, <city>Tomsk</city>, <country>Russian Federation</country></aff><author-notes><corresp id="cor0847"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="966">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S477</fpage><lpage>S478</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382400991Xa.pdf"/><abstract><sec id="sec5094"><title>Introduction</title><p>The study of the phenomenon of deformation of mental disorders, clinical dynamics, behaviors, and adaptations in case of abuse of synthetic cannabinoids is of relevance.</p></sec><sec id="sec5095"><title>Objectives</title><p>To study the phenomenon of deformation of mental disorders, clinical dynamics, behaviors, and adaptations in case of abuse of synthetic cannabinoids</p></sec><sec id="sec5096"><title>Methods</title><p>Catamnestic, clinical-psychopathological methods (PANS, SANS, CGI, MMPI, CGI, STAI, LSI, TPA, ICD-10), statistical (Python 3.11.0).</p></sec><sec id="sec5097"><title>Results</title><p>291 men (age from 18 to 35 years) were examined: 240 - F12.2xx, of which 98 - F60.xx-F62.xx, 142 - F20.xx and 51 - F20.xx without substance abuse. The study took place from 2018 to 2023 based on psychiatric institutions of the Russia, Tomsk region, St. Petersburg, Noyabrsk and Nizhnevartovsk.</p></sec><sec id="sec5098"><title>Conclusions</title><p>The phenomenon of abuse of synthetic cannabinoids is a factor in the deformation of mental disorders. Persistent exogenous visual and delusional disorders contribute to the symptoms of exacerbations of schizophrenia; schizophrenic symptoms are included in psychotic episodes in personality disorders. In remission of schizophrenia, there is a quasi-adaptation from socio-professional environments, mostly addictive and criminalized, a pronounced smoothing of emotional impoverishment, a stigmatizing symptom is mainly a volitional defect, as well as frequent rehospitalizations not indirectly related to drugs. In remissions of drug use in patients with personality disorder, persistent schizophrenia of behavior. In patients with schizophrenia and patients with personality disorders, there is a distortion of behavior with a predominance in patterns of inclinations to delict, nonconformity, isolation in an addictive environment, suspiciousness. Drug abuse may initiate auto-aggression predominantly in individuals with personality disorders and to a lesser extent in patients with schizophrenia. True suicides in drug users include only episodes with depressive symptoms.</p></sec><sec id="sec5099"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>